According to FutureWise analysis the market for Antibody Fragments in 2023 is US$ 8.04 billion, and is expected to reach US$ 12.93 billion by 2031 at a CAGR of 6.10%.
Fragment antibodies are fragments of the binding end of a monoclonal antibody (mAb) and are a small but powerful tool to fight disease. While mAbs range from around 150kDa, fragment antibodies are as small as 3kDa and are used in various applications. Their small size helps access difficult-to-reach therapeutic targets on tissues and cells and penetrate tumors more effectively. These small fragments can also be useful for rapidly blocking signaling molecules or receptors. Fragments can also minimize other downstream effects on the immune system because they do not have the bulk of a whole antibody. Fragment antibodies are emerging as great tools in imaging and diagnostics because they are capable of detecting cellular proteins with high affinity and specificity. They can be linked to radioisotopes, fluorescent molecules, or enzymes that tag specific patient biomarkers. They also have a shorter half-life in the body, which results in faster clearance and may result in fewer risks of side effects from potentially invasive diagnostic agents.
There are two groups of antibody fragments of primary interest: (a) antigen-binding fragments such as Fab and (b) class-defining fragments like Fc that do not bind antigen. Several antigen-binding fragments are viable, but each contains at least the variable regions of heavy and light immunoglobulin chains (VH and VL) held together, usually by disulfide bonds, to preserve the antibody-binding site. Fc fragments comprise the heavy chain constant region (Fc region) of immunoglobulin and play a vital role in mediating cellular effector functions.
FutureWise Market Research has published a report that provides an insightful analysis antibody fragments market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.
According to the analysis conducted by FutureWise research analysts, antibody fragments market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.